Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 8, 2012

View Archived Issues

Kyowa Hakko Kirin reviews accomplishments of 2011

RNA-loaded dendritic cell vaccine shows promise combined with sunitinib

EpiCept seeks fast track designation for AmiKet

African sleeping sickness drug shows potential to treat leishmaniasis

Foretinib shows promise in large papillary renal cell carcinoma study

New vaccines for human papillomavirus prepared in China

Artificial Cell Technologies patents novel RSV vaccines

New phase I safety data presented on stroke therapy

Scientists at Calmune prepare novel antibodies for RSV infection

Bradykinin B1 receptor antagonist reduces pain in vivo

Vertex Pharmaceuticals claims novel HCV NS5B inhibitors

Rib-X Pharmaceuticals receives milestone payment under RX-04 collaboration

Amicus receives grant for Pompe's disease program

Japanese authorities remove condition for approval of Tarceva in NSCLC

Merck & Co. recaps milestones of fourth quarter and full year 2011

Erivedge launched in U.S.

Alexion Pharmaceuticals completes acquisition

FDA sets date for crofelemer NDA

Phase II study of ziprasidone commences in Japan

Line extension for Vyvanse in U.S.

Omeros provides update on phase III OMS-302 trial

Bio-Path completes treatment of second cohort in BP-100-1.01 study

Health Canada approves ipilimumab

FDA grants priority review for pertuzumab

Orion plans new studies of inhalable budesonide/formoterol combination

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...